
Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical ...
In heart failure, the Kansas City Cardiomyopathy Questionnaire (KCCQ) has been qualified by the U.S. Food and Drug Administration as a Clinical Outcome Assessment and recommended as a performance measure for quantifying the quality of care.
Development and evaluation of the Kansas City Cardiomyopathy ...
The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a new, self-administered, 23-item questionnaire that quantifies physical limitations, symptoms, self-efficacy, social interference and quality of life.
The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a 23-item self-administered questionnaire developed to independently measure the patient’s perception of...
Development and evaluation of the Kansas City Cardiomyopathy ...
All scales of the KCCQ were substantially more sensitive to the important clinical change experienced by this cohort, namely recovering from a severe exacerbation of CHF, than either the LiHFe or the SF-36. Whereas the KCCQ scores improved by 15.4 to 40.4 points, the largest change in either the LiHFe or the SF-36 was 11.3 points.
堪萨斯城心肌病调查问卷(KCCQ-23 问卷) - MedSci
2、kccq评分也可以用于治疗前后的评价,如果评分提高5分,称为小改变,提高达10分,称为中到大改变,提高超过20分则称为大改变。 3、OSS,FSS,CSS得分计算为各子项得分的和的平均数,并不是原始条目得分的平均数
Interpreting the Kansas City Cardiomyopathy Questionnaire in …
This review describes how to interpret the KCCQ, how it should be analyzed in clinical trials to maximize the interpretability of results, and how it can be used in clinical practice and population health. By providing a deeper understanding of the KCCQ, it is hoped that its use can further improve the patient-centeredness of heart failure care.
2012年7月9日 · Cardiomyopathy Questionnaire (KCCQ) is a disease-specific instrument originally designed to describe and monitor health status in patients with heart failure.11 The KCCQ has been extensively tested for reliability and validity in various heart failure populations11–13 and has been shown to predict © 2012 American Heart Association, Inc.
JACC State-of-the-Art Review - ScienceDirect
2020年11月17日 · In heart failure, the Kansas City Cardiomyopathy Questionnaire (KCCQ) has been qualified by the U.S. Food and Drug Administration as a Clinical Outcome Assessment and recommended as a performance measure for quantifying the quality of care.
Kansas City Cardiomyopathy Questionnaire (KCCQ) Explained
2025年2月11日 · What is the Kansas City Cardiomyopathy Questionnaire? The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a self-administered, 23-item questionnaire that quantifies five subscales of (1) physical limitations, (2) symptoms, (3) self-efficacy, (4) social interference, and (5) quality of life in heart failure (HF) patients.
Interpreting the Kansas City Cardiomyopathy Questionnaire in …
2020年11月17日 · This review describes how to interpret the KCCQ, how it should be analyzed in clinical trials to maximize the interpretability of results, and how it can be used in clinical practice and population health. By providing a deeper understanding of the KCCQ, it is hoped that its use can further improve the patient-centeredness of heart failure care.